(Q33712240)

28 July 2017

1 reference

title

Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies (English)

1 reference

28 July 2017

main subject

traumatic brain injury

0 references

author name string

Bullock MR

series ordinal

1

1 reference

28 July 2017

Lyeth BG

series ordinal

2

1 reference

28 July 2017

Muizelaar JP

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

45

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

207-17; discussion 217-20

1 reference

Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Cognitive sequelae of severe head injury in relation to the Glasgow Outcome Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

A phase II study of moderate hypothermia in severe brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Mild traumatic brain injury enhances muscarinic receptor-linked inositol phosphate production in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Efficacy of competitive vs noncompetitive blockade of the NMDA channel following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Jugular venous desaturation and outcome after head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

The pathology of brain ischaemia and possibilities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Cognitive impairment following traumatic brain injury: the effect of pre- and post-injury administration of scopolamine and MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Pretreatment with phencyclidine, an N-methyl-D-aspartate antagonist, attenuates long-term behavioral deficits in the rat produced by traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Glucose hypermetabolism after acute subdural hematoma is ameliorated by a competitive NMDA antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Disability after severe head injury: observations on the use of the Glasgow Outcome Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Thresholds of focal cerebral ischemia in awake monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Failure of cerebral blood flow-metabolism coupling after acute subdural hematoma in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Effect of neuroprotective N-methyl-D-aspartate antagonists on increased intracranial pressure: studies in the rat acute subdural hematoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Effects of scopolamine treatment on long-term behavioral deficits following concussive brain injury to the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: Studies on kinin formation in focal and perifocal brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Treatment of traumatic brain injury with moderate hypothermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Pitfalls and advances from the international tirilazad trial in moderate and severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

A mechanistic analysis of nondisruptive axonal injury: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Effects of the N-methyl-D-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Effect of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Documented reversal of global ischemia immediately after removal of an acute subdural hematoma. Report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Ketamine alters calcium and magnesium in brain tissue following experimental head trauma in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

A use-dependent sodium channel antagonist, 619C89, in reduction of ischemic brain damage and glutamate release after acute subdural hematoma in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

The neuroprotective effect of the forebrain-selective NMDA antagonist CP101,606 upon focal ischemic brain damage caused by acute subdural hematoma in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1: Cerebral exposure to bradykinin and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Atropine in the treatment of closed head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Failure of prophylactic barbiturate coma in the treatment of severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Effect of THAM upon outcome in severe head injury: a randomized prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Amelioration of mitochondrial function by a novel antioxidant U-101033E following traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Mitochondrial dysfunction after experimental traumatic brain injury: combined efficacy of SNX-111 and U-101033E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Dynamic changes in local cerebral glucose utilization following cerebral concussion in rats: evidence of a hyper- and subsequent hypometabolic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199908000-00001

10.1097/00006123-199908000-00001

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference